(Q84715355)

English

Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell

scientific article published on 10 August 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

S Lee

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Y H Park

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

K H Kim

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

E Y Cho

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Y C Ahn

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

K Kim

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Y-M Shim

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

J S Ahn

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

K Park

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Y-H Im

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

10 August 2010

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

103

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

845-851

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605831

0 references

Chemotherapy in esophageal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of thymidine phosphorylase expression in breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic and predictive value of thymidine phosphorylase activity in early-stage breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic significance of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expressions in breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advances and challenges in fluoropyrimidine pharmacogenomics and pharmacogenetics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients with ERCC1-negative locally advanced esophageal cancers may benefit from preoperative chemoradiotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The dual role of thymidine phosphorylase in cancer development and chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thymidine phosphorylase (TP) activation: convenience through innovation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20700125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6605831

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20700125%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84715355&oldid=2035086823"